Prescription drug · ANDA
Loteprednol Etabonate NDC 0574-4080
Loteprednol etabonate 2 mg/mL · Suspension/ drops · Ophthalmic · Padagis US LLC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 0574-4080-05 | 00574408005 | 1 BOTTLE, DROPPER in 1 CARTON (0574-4080-05) / 5 mL in 1 BOTTLE, DROPPERMarketed from Mar 31, 2026 | |
| 0574-4080-10 | 00574408010 | 1 BOTTLE, DROPPER in 1 CARTON (0574-4080-10) / 10 mL in 1 BOTTLE, DROPPERMarketed from Mar 31, 2026 |
How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Loteprednol Etabonate
- Generic name (nonproprietary)
- loteprednol etabonate
- Active ingredients
- Loteprednol etabonate — 2 mg/mL
- Dosage form
- Suspension/ drops
- Route
- Ophthalmic
- Labeler
- Padagis US LLCNDC labeler code 0574
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 215203
- Marketing start
- Listing expires
- Other FDA classes
- Corticosteroid Hormone Receptor Agonists (Mechanism)
- Identifiers
- Product ID 0574-4080_d37c000f-f673-4dce-be90-8b6f47777b7bSPL ID d37c000f-f673-4dce-be90-8b6f47777b7bSPL set ID 63372922-4d41-4d81-8d9b-eebaf44acabfRxCUI 311381UNII YEH1EZ96K6
- Pharmacologic class
- Corticosteroid
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Ophthalmic products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N400574408005followed by a unit qualifier and the quantityPackage 00574-4080-05. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS AND USAGE Loteprednol etabonate ophthalmic suspension is indicated for the temporary relief of the signs and symptoms of seasonal allergic conjunctivitis.
Excerpt only. Read the full label for complete information.
About NDC 0574-4080
- What is NDC 0574-4080?
- 0574-4080 is the product NDC for Loteprednol Etabonate, Loteprednol etabonate 2 mg/mL suspension/ drops, listed with the FDA by Padagis US LLC. It has 2 package NDCs, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Loteprednol Etabonate.
- What is the active ingredient?
- Loteprednol etabonate.
- Who is the labeler?
- Padagis US LLC, NDC labeler code 0574. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Loteprednol Etabonate?
- 18 other product NDCs are listed under this name. See all Loteprednol Etabonate NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Loteprednol Etabonate products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Loteprednol Etabonate | Loteprednol etabonate 5 mg/mL | Suspension/ dropsOphthalmic | Sentiss Pharmaceuticals LLC | 70244-034 | 70244-0034-0170244-0034-0270244-0034-03 |
| Loteprednol Etabonate | Loteprednol etabonate 2 mg/mL | Suspension/ dropsOphthalmic | Sentiss Pharmaceuticals LLC | 70244-035 | 70244-0035-0170244-0035-02 |
| Loteprednol Etabonate | Loteprednol etabonate 5 mg/g | GelOphthalmic | Sentiss Pharmaceuticals LLC | 70244-036 | 70244-0036-01 |
| Loteprednol Etabonate | Loteprednol etabonate 5 mg/mL | Suspension/ dropsOphthalmic | Padagis US LLC | 0574-4135 | 00574-4135-0500574-4135-1000574-4135-15 |
| loteprednol etabonate | Loteprednol etabonate 5 mg/mL | SuspensionOphthalmic | Lupin Pharmaceuticals, Inc. | 70748-300 | 70748-0300-0170748-0300-02 |
| Loteprednol Etabonate | Loteprednol etabonate 5 mg/mL | Suspension/ dropsOphthalmic | Amneal Pharmaceuticals NY LLC | 60219-1362 | 60219-1362-0160219-1362-0260219-1362-03 |
| loteprednol etabonate | Loteprednol etabonate 2 mg/mL | Suspension/ dropsOphthalmic | Amneal Pharmaceuticals NY LLC | 60219-1366 | 60219-1366-03 |
| loteprednol etabonate | Loteprednol etabonate 2 mg/mL | Suspension/ dropsOphthalmic | Amneal Pharmaceuticals NY LLC | 60219-1367 | 60219-1367-06 |
| Loteprednol Etabonate | Loteprednol etabonate 5 mg/mL | Suspension/ dropsOphthalmic | NorthStar RxLLC | 72603-324 | 72603-0324-0172603-0324-0272603-0324-03 |
| loteprednol etabonate | Loteprednol etabonate 2 mg/mL | Suspension/ dropsOphthalmic | Bausch & Lomb Americas Inc. | 82260-361 | 82260-0361-05 |